导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 1.43% | 506/1050 |
| 近一周 | -1.98% | 397/1104 |
| 近一月 | -1.33% | 174/1102 |
| 近一季 | 2.07% | 175/1092 |
| 近半年 | -0.31% | 426/1070 |
| 近一年 | 7.52% | 403/1018 |
| 近两年 | 31.35% | 665/926 |
| 近三年 | 4.35% | 632/834 |
| 成立以来 | 63.50% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-3.67% 753/1070 |
5.62% 610/1101 |
- - |
- - |
| 2025 | 22.67% 622/1065 |
2.14% 640/1014 |
1.49% 552/1038 |
14.51% 751/1050 |
3.34% 230/1065 |
| 2024 | -14.77% 851/1011 |
-5.07% 569/960 |
-3.15% 515/983 |
2.48% 930/991 |
-9.53% 888/1011 |
| 2023 | -31.14% 819/952 |
-3.45% 760/880 |
-14.94% 856/895 |
-15.93% 796/915 |
-0.26% 131/952 |
| 2022 | -23.40% 448/867 |
-21.69% 621/773 |
14.72% 127/806 |
-7.49% 120/845 |
-7.84% 731/867 |
| 2021 | 36.87% 40/740 |
-1.32% 199/580 |
19.90% 163/659 |
3.93% 149/704 |
11.31% 49/740 |
| 2020 | 58.05% 202/554 |
-1.56% 199/419 |
18.55% 309/466 |
17.37% 92/517 |
15.39% 197/554 |
| 2019 | 58.10% 90/410 |
39.08% 73/1149 |
-4.22% 662/1231 |
9.07% 128/390 |
8.80% 205/410 |
| 2018 | -33.95% 261/349 |
- - |
- - |
- - |
-5.44% 64/1080 |
| 2017 | 17.59% 89/285 |
- - |
- - |
- - |
- - |
| 2016 | -8.20% 62/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 嘉实逆向策略股票 VS. 东吴新产业精选股票A(580008) |